Author: Yilmaz A. Reiss C. Tantawi O. Weng A. Stumpf C. Raaz D. Ludwig J. Berger T. Steinkasserer A. Daniel W.G. Garlichs C.D.
Publisher: Elsevier
ISSN: 0021-9150
Source: Atherosclerosis, Vol.172, Iss.1, 2004-01, pp. : 85-93
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Direct Vascular Effects of HMG-CoA Reductase Inhibitors
Trends in Cardiovascular Medicine, Vol. 10, Iss. 4, 2000-05 ,pp. :
HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice
By Zineh Issam
Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. :
Advantages of Lipid-Lowering Therapy in Cerebral Ischemia: Role of HMG-CoA Reductase Inhibitors
Cerebrovascular Diseases, Vol. 11, Iss. 1, 2010-04 ,pp. :
Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. :